E-LIB Suche - Ergebnisse für: Arrillaga-Romany, I

1

P11.46.A ACTION: A RANDOMIZED PHASE 3 STUDY OF DORDAVIPRONE..:

Arrillaga-Romany, I ; Lassman, A ; McGovern, S L...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii84-ii84 , 2023

Link: https://doi.org/10.1093/..

2

JS04.6.A The landscape of tumor cell states and spatial org..:

Liu, I ; Jiang, L ; Samuelsson, E...
Neuro-Oncology. 24 (2022) Supplement_2 - p. ii7-ii7 , 2022

Link: https://doi.org/10.1093/..

3

PL3.1 A phase 1, open-label, perioperative study of ivoside..:

Mellinghoff, I K ; Wen, P Y ; Taylor, J W...
Neuro-Oncology. 21 (2019) Supplement_3 - p. iii2-iii2 , 2019

Link: https://doi.org/10.1093/..

4

P06.11.B NEUROTOXICITY AND MANAGEMENT OF PRIMARY AND SECOND..:

Karschnia, P ; Arrillaga-Romany, I C ; Eichler, A...
Neuro-Oncology. 25 (2023) Supplement_2 - p. ii47-ii48 , 2023

Link: https://doi.org/10.1093/..

5

The landscape of tumor cell states and spatial organization..:

Liu, Ilon ; Jiang, Li ; Mire, Hafsa M...
Nature Genetics Vol. 54, Issue 12, p. 1881-1894. , 2022

Link: http://hdl.handle.net/19..

6

Long-term outcomes and late toxicity of adult medulloblasto..:

Saraf, Anurag ; Yock, Torunn I ; Niemierko, Andrzej...
Neuro-Oncology. 24 (2022) 12 - p. 2180-2189 , 2022

Link: https://doi.org/10.1093/..

7

Mutant IDH inhibitors induce lineage differentiation in IDH..:

Spitzer, Avishay ; Gritsch, Simon ; Nomura, Masashi...
Cancer Cell. 42 (2024) 5 - p. 904-914.e9 , 2024

Link: https://doi.org/10.1016/..

8

ACTION: a randomized phase 3 study of ONC201 (dordaviprone)..:

Arrillaga-Romany, Isabel ; Lassman, Andrew ; McGovern, Susan L...
Neuro-Oncology. 26 (2024) Supplement_2 - p. S173-S181 , 2024

Link: https://doi.org/10.1093/..

9

Demonstrated efficacy and mechanisms of sensitivity of ONC2..:

Arrillaga-Romany, Isabel ; Miller, Julie J
Neuro-Oncology. , 2024

Link: https://doi.org/10.1093/..

10

Selective DRD2 antagonist and ClpP agonist ONC201 in a recu..:

Odia, Yazmin ; Hall, Matthew D ; Cloughesy, Timothy Francis...
Neuro-Oncology. 26 (2024) Supplement_2 - p. S165-S172 , 2024

Link: https://doi.org/10.1093/..

11

CTIM-38. NEUROTOXICITY AND MANAGEMENT OF PRIMARY AND SECOND..:

Karschnia, Philipp ; Arrillaga-Romany, Isabel ; Eichler, April...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v71-v71 , 2023

Link: https://doi.org/10.1093/..

12

TMET-02. CLINICAL EFFICACY OF ONC201 IN H3K27M-MUTANT DIFFU..:

Venneti, Sriram ; Kawakibi, Abed Rahman ; Ji, Sunjong...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v272-v272 , 2023

Link: https://doi.org/10.1093/..

13

CTIM-37. A PILOT STUDY OF AXICABTAGENE CILOLEUCEL (AXI-CEL)..:

Nayak, Lakshmi ; Falvey, Caroline ; Bouvier, Riemke...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v71-v71 , 2023

Link: https://doi.org/10.1093/..

14

CTNI-47. DOSE ESCALATION OF ASTX727 IN ADULT PATIENTS WITH ..:

Arrillaga-Romany, Isabel ; Miller, Julie ; Dietrich, Jorg...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v85-v86 , 2023

Link: https://doi.org/10.1093/..

15

NCOG-34. BRAIN PET IMAGING OF PAIRED HELICAL FILAMENT TAU I..:

Parsons, Michael ; Von Imhof, Liesel ; Eckbo, Ryan...
Neuro-Oncology. 25 (2023) Supplement_5 - p. v221-v221 , 2023

Link: https://doi.org/10.1093/..